Netilmicin in Gram-Negative Bacterial Infections

Netilmicin, a new semisynthetic aminoglycoside, was used in the treatment of 42 patients with serious gram-negative bacterial infections. Of the 40 evaluable patients, 24 (60%) were cured, and 8 (20%) had a favorable clinical response, for a total clinical response rate of 80%. Eight patients failed...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Snydman, David R., Tally, Francis P., Landesman, Sheldon H., Barza, Michael, Gorbach, Sherwood L.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1979
Teme:	Pharmacology and Therapeutics
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352599/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/426506/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.15.1.50
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!